占

占玲俊｜Lingjun Zhan

chinese academy of medical sciences and peking union medical college邮箱:zhanlj@cnilas.org

H指数:17

被引数:720

浏览量:0

个人简介

"1999年-2004年武汉大学医学部获学士学位 2004年-2006年武汉大学医学部基础医学院免疫系获硕士学位 2006年-2009年中国医学科学院/北京协和医学院获博士学位"

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Transmembrane delivery of antimicrobial peptides by engineered eCIS into macrophages for intracellular mycobacteria elimination

工程化eCIS介导抗菌肽跨膜递送至巨噬细胞以清除细胞内分枝杆菌

Science Advances

IF12.5

2026-09-230

Targeting the GPR183/EBI2‒oxysterol axis in tuberculosis: Immunometabolic regulation and prospects for host-directed therapy

靶向结核病中GPR183/EBI2-氧甾醇轴：免疫代谢调控及宿主导向疗法的展望

Clinical and Translational Medicine

IF6.8

2026-09-130

OAAI

A copper uptake ABC transport system is essential for Mycobacterium tuberculosis virulence

铜摄取ABC转运系统对于结核分枝杆菌毒力至关重要

Emerging Microbes & Infections

IF0

2026-05-250

OAAI

CRISPR Screening and Comparative LC-MS Analysis Identify Genes Mediating Efficacy of Delamanid and Pretomanid against Mycobacterium tuberculosis

CRISPR筛选和比较lc-ms分析鉴定介导Delamanid和Pretomanid对结核分枝杆菌的功效的基因

ADVANCED SCIENCE

IF14.1

2024-08-200

Flu-CED: A comparative transcriptomics database of influenza virus-infected human and animal models

ANIMAL MODELS AND EXPERIMENTAL MEDICINE

IF3.4

2024-02-200

OAAI

Editorial: What does not kill you makes you stronger: Interactions between environmental stresses and microbial virulence

FRONTIERS IN MICROBIOLOGY

IF4.5

2023-01-090

OAAI

Application of combined CRISPR screening for genetic and chemical-genetic interaction profiling in Mycobacterium tuberculosis

SCIENCE ADVANCES

IF12.5

2022-11-2314

OAAI

The double-sided effects of Mycobacterium Bovis bacillus Calmette-Guerin vaccine

NPJ VACCINES

IF6.5

2021-01-2532

OAAI

Downregulation of GPR183 on infection restricts the early infection and intracellular replication of mycobacterium tuberculosis in macrophage

MICROBIAL PATHOGENESIS

IF3.5

2020-08-0111

OAAI

The correlation of drug resistance and virulence in Mycobacterium tuberculosis

BIOSAFETY AND HEALTH

IF3

2020-03-0115

OAAI

Tuberculosis vaccine development: from classic to clinical candidates

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

IF3

2020-02-1542

OAAI

Identification of pyrvinium pamoate as an anti-tuberculosis agent in vitro and in vivo by SOSA approach amongst known drugs

在已知药物中通过SOSA方法在体外和体内鉴定双羟萘酸吡啶作为抗结核药

EMERGING MICROBES & INFECTIONS

IF7.5

2020-02-0410

OAAI

HR+/HER2-ADVANCED BREAST CANCER TREATMENT, DISEASE PROGRESSION, AND SURVIVAL IN ARGENTINA, BRAZIL, CHILE, COLOMBIA, AND MEXICO

VALUE IN HEALTH

IF6

2018-10-010

OAAI

Toll-Like Receptor 8 Agonist Strengthens the Protective Efficacy of ESAT-6 Immunization to Mycobacterium tuberculosis Infection

FRONTIERS IN IMMUNOLOGY

IF5.9

2018-01-2415

OAAI

Animal Models for Tuberculosis in Translational and Precision Medicine

FRONTIERS IN MICROBIOLOGY

IF4.5

2017-05-0445

OAAI

Inhibition of TLR8 mediated signaling promotes BCG induced apoptosis in THP-1 cells

MICROBIAL PATHOGENESIS

IF3.5

2016-04-016

PREAI

Prophylactic Use of Ganoderma lucidum Extract May Inhibit Mycobacterium tuberculosis Replication in a New Mouse Model of Spontaneous Latent Tuberculosis Infection

FRONTIERS IN MICROBIOLOGY

IF4.5

2016-01-088

OAAI

A single-amino-acid substitution in the HA protein changes the replication and pathogenicity of the 2009 pandemic A (H1N1) influenza viruses in vitro and in vivo

VIROLOGY JOURNAL

IF3.8

2010-11-1833

OAAI

The low-salt stimulon in Vibrio parahaemolyticus

INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY

IF5.2

2010-01-3135

PREAI

Direct and negative regulation of the sycO-ypkA-ypoJ operon by cyclic AMP receptor protein (CRP) in Yersinia pestis

BMC MICROBIOLOGY

IF4.2

2009-08-2531

OAAI

占玲俊｜Lingjun Zhan

个人简介

教育背景

工作经历

荣誉奖项

研究方向